The importance of tau phosphorylation for neurodegenerative diseases

Research output: Contribution to journalBook/Film/Article reviewpeer-review

285 Citations (Scopus)


Fibrillar deposits of highly phosphorylated tau are a key pathological feature of several neurodegenerative tauopathies including Alzheimer’s disease (AD) and some frontotemporal dementias. Increasing evidence suggests that the presence of these end-stage neurofibrillary lesions do not cause neuronal loss, but rather that alterations to soluble tau proteins induce neurodegeneration. In particular, aberrant tau phosphorylation is acknowledged to be a key disease process, influencing tau structure, distribution, and function in neurons. Although typically described as a cytosolic protein that associates with microtubules and regulates axonal transport, several additional functions of tau have recently been demonstrated, including roles in DNA stabilization, and synaptic function. Most recently, studies examining the trans-synaptic spread of tau pathology in disease models have suggested a potential role for extracellular tau in cell signaling pathways intrinsic to neurodegeneration. Here we review the evidence showing that tau phosphorylation plays a key role in neurodegenerative tauopathies. We also comment on the tractability of altering phosphorylation-dependent tau functions for therapeutic intervention in AD and related disorders.
Original languageEnglish
JournalFrontiers in Neurology
Issue number83
Publication statusPublished - 1 Jul 2013


  • Acknowledged-BRU-13/14
  • Acknowledged-BRU
  • Acknowledged-BRC


Dive into the research topics of 'The importance of tau phosphorylation for neurodegenerative diseases'. Together they form a unique fingerprint.

Cite this